Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor RVPH?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor RVPH

Key Statistics

About

Reviva Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing therapies that address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Reviva's primary focus is developing its lead product candidate, RP5063 (brilaroxazine), for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.

Sector

Manufacturing

Industry

Medicinal and Botanical Manufacturing

revivapharma.com →